Enhanced external counterpulsation improves systolic blood pressure in patients with refractory angina.

| September 4, 2009

Campbell AR, Satran D, Zenovich AG, Campbell KM, Espel JC, Arndt TL, Poulose AK, Boisjolie CR, Juusola K, Bart BA, Henry TD. Minneapolis Heart Institute Foundation at Abbott Northwestern Hospital, Minneapolis, MN 55407, USA. BACKGROUND: Enhanced external counterpulsation (EECP) is a noninvasive treatment of patients with refractory angina. The immediate hemodynamic effects of EECP are […]

Multiple Presentations at the European Society of Cardiology Congress Document EECP Promotes Coronary Collateral Flow Leading to Sustained Clinical Improvement

| September 1, 2009

WESTBURY, N.Y.–(BUSINESS WIRE)–Vasomedical, Inc. (“Vasomedical”) (OTC: VASO – News), a world leader in the noninvasive treatment of cardiovascular diseases, today announced that evidence presented by Dr. Eva-Elina Buschmann on behalf of the European Arteriogenesis Network 2 Trial, at the 2009 European Society of Cardiology (ESC) Congress taking place in Barcelona, Spain, demonstrates that EECP® therapy […]


| August 27, 2009

In the Prospective Evaluation of EECP in Congestive Heart Failure (PEECH) trial, EECP improved exercise duration, symptom status, and QOL in patients with mild-to-moderate heart failure who were already receiving optimal medical therapy. The PEECH trial, reported at the 2005 ACC meeting by Arthur M. Feldman, MD, PhD, FACC, enrolled 187 patients with ischemic or […]

Dr. Dean Ornish: Resuscitating Health Care Reform

| August 10, 2009

Mon, 08/10/2009 – 05:01 — popdd.com – Health reform is in danger of failing because the focus has been too much on who is covered and not enough on what is covered. Health care reform is primarily about health insurance reform, with the main battle being over coverage and the payment system. Of course, we need […]

Medicare Increases Rates for Vasomedical EECP Therapy for 2008

| July 27, 2009

WESTBURY, N.Y. — Vasomedical, Inc. (“Vasomedical”) (OTC: VASO.OB), a world leader in the noninvasive treatment of cardiovascular diseases, today announced that Medicare has increased reimbursement payment rates for EECP([R]) therapy for 2008. The new rates, recently published by the Centers for Medicare and Medicaid Services (CMS), are effective immediately for the first six months of […]

External Counterpulsation Device – Simply Effective

| July 14, 2009

New YM – 7 ECP System combines proven medical technology with styling in a compact model that’s easy to operate. As a result, therapists use it with confidence and physicians rely on its performance. All information during therapy is displayed on one screen, without complicated pulldown menus, mouse-pointers, or keyboard entry. Just touch the controls […]

Pneumatic External Counterpulsation (PECP): A New Treatment Option for Therapy-Resistant Inner Ear Disorders?

| February 3, 2009

In Germany, the standard therapy for sudden deafness and tinnitus (persistent ringing in the ears) involves drug therapy designed to improve blood flow to the inner ear. Werner’s group had previously demonstrated an increase in carotid artery blood flow with EECP (described in Germany as PECP).  In this study, 30 patients with acute hearing disorders and/or […]

The Effects of External Counter PulsationTherapy on Circulating Endothelial Progenitor

| February 3, 2009


Abstract 2414: Enhanced External Counterpulsation Therapy Improves Angina and Functional Status in Patients with Severe Left Ventricular Systolic Dysfunction

| February 3, 2009

Enhanced external counterpulsation (EECP) therapy, a non-invasive assisted circulation device, can be safely performed in patients with severe symptomatic left ventricular systolic dysfunction (LVSD). Little information is available about the efficacy of this therapy in such patients. We analyzed the data on 2454 patients (mean age 67 ± 11 years, 74% men) enrolled in the […]

Enhanced External Counterpulsation Arrests the Progression of Atherosclerosis by Regulating Cellular Apoptosis and Proliferation Signaling Pathway

| February 3, 2009

Shear stress may be the most crucial local factor affecting atherogenesis. Enhanced External Counterpulsation (EECP) has been documented to increase arterial wall shear stress in vivo. We hypothesize that chronic exposure to increased pulsatile shear stress by EECP arrests the progression of atherosclerosis due to hypercholesterolemia. Forty-eight pigs were randomized to usual diet (n = […]